Critical Metals Corp. heads into its earnings release tomorrow with the borrow market near fully locked out, short interest running at nearly 18% of the float, and the stock down 9% on Tuesday alone — a setup where the lending data and the price action are telling the same uncomfortable story.
The borrow market is about as tight as it gets. Availability has collapsed to just 0.44% — meaning for every 100 shares already lent out, fewer than one share remains available to borrow. That reading has been essentially at zero for most of the past month, and cost to borrow has climbed to 34.2%, up 16% on the week and double the level seen in early May when it briefly touched 62%. Short interest itself dipped about 10% from its late-May peak above 24 million shares but remains stubbornly elevated at 17.75% of free float — still one of the heavier short positions in the junior critical metals space. With the lending pool fully absorbed and borrow costs elevated, any covering pressure ahead of tomorrow's print has almost nowhere to go. Days to cover runs at just over two, which limits immediate squeeze dynamics, but the structural tightness in the borrow market means any sudden demand for new shorts cannot be accommodated at current rates.
The ORTEX short score underlines how contested this stock is. At 80.2, the score has crept higher almost every day for two weeks, reflecting the combination of high short interest, near-zero availability, and elevated borrow costs. The factor rank on utilization sits at the first percentile — the single tightest cohort in the database. Options positioning, by contrast, is unusually calm: the put/call ratio at 0.51 is fractionally below its 20-day average of 0.52, suggesting options traders are neither rushing to hedge nor speculating aggressively into the event. The contrast between the extreme tightness in the lending market and the almost neutral options skew is the clearest tension in the current setup.
Analyst coverage remains thin and dated. Freedom Broker initiated with a Buy and a $15 target in March, and Clear Street put on a Buy at $12 back in September 2025. With the stock currently at $9.56, both targets imply meaningful upside — but the latest coverage is now several months old, and neither firm qualifies as a bellwether name. The mean target of $17 should be treated with caution given the staleness. Institutionally, the ownership picture is dominated by European Lithium Limited, which holds 31% of shares — a concentration that limits the freely tradeable float considerably and helps explain why the borrow market remains so structurally tight. BlackRock added roughly 734,000 shares through May, and Morgan Stanley added nearly 1.4 million in Q1, small increments relative to the overall register but notable given the heavily shorted backdrop.
Prior earnings reactions offer a wide range of outcomes. The January 2026 print delivered a 35% one-day gain and a near-116% five-day move — the single biggest post-earnings swing in the data. The March events reversed sharply, with the stock dropping 8% the next day and extending losses of 14% and 17% over the following five sessions. Tuesday's 9% drop already matched the size of those post-event declines before the release has even occurred. Peers also slipped on the day: ABAT fell 8.6% and USAR dropped 5.6%, suggesting the sector broadly faced selling pressure rather than anything company-specific, though LAC and TMQ held losses to 2-4% and posted positive weeks.
The immediate focus for Thursday is whether the earnings print shifts the balance between a locked borrow market and a stock already pricing in deterioration — and whether the few remaining available-to-borrow shares see any movement in the hours after the release.
See the live data behind this article on ORTEX.
Open CRML on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
